Tagged with GE

Generics The Moroccan pharma sector is increasingly looking not just to Europe, but also to Africa. Moroccan investment in distribution to African countries is increasing. But key opinion leaders say that challenges remain. For example, Morocco would benefit from a direct export platform. “In the past Morocco always looked towards the north…

Boehringer Ingelheim Sirilak Suteekul explains the organization’s success in Thailand over the last couple of years, Thailand’s untapped potential as a regional center in Southeast Asia and how innovation adds value to society. As managing director of the organization for nearly two years, what have been your major challenges and accomplishments since…

locals The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing, his company’s key role as an educator and advisor to the industry with regards to international regulatory standards, and unique role as a supplier that provides robust support services,…

locals The CEO of Centurion shares his ambitious vision for the company’s expansion into plasma products, biotech, orphan drugs, and generic injectables over the coming years, while simultaneously developing sales in more than twenty countries across the EU, CIS, GCC and MENA regions. As a company working on bringing biotech production to Turkey,…

locals Imuneks is currently operating in the OTC market, but with three supergeneric products ready to market on the RX side, the firm has the potential to soon become one of Turkey’s most innovative pharmaceutical players.  To begin, could you please introduce yourself and Imuneks to our readers around the world?…

investment agency The Puerto Rico Industrial Development Company (PRIDCO) is a government agency underneath the Puerto Rican Department of Economic Development and Commerce designed to facilitate industrial investments in the country from abroad. Antonio Medina Comas, PRIDCO’s executive director, discusses the agency’s critical job in stimulating the economy while highlighting recent successes.…

Generics The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is much room for the generics market to grow given that it currently represents just one third of the total private market and how as the…

Chiesi Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager of Chiesi Turkey. How important is it for the government to clarify the incentives that have been discussed? The healthcare system in Turkey has undergone the largest transition in its…

Dr. Reddy's One of the new generation of country managers in Romania describes the importance of brand consciousness in the local market. In a highly intriguing and insightful interview, he outlines his ambitious strategy to buck the trend and focus his team’s energies on building brand loyalty and identity. Tell us about…

Dr Reddy's The country manager of Dr. Reddy´s South Africa explains that while the perception of the quality of generics has improved in South Africa, there is still a long way to go. She reveals how the company is currently amongst the top ten generic companies in the country, with the ambition…

association The CEO of NAPM reveals how the main challenge facing his members is the length of time needed to register a generic product, taking up to four years and acting as a significant block on investment, discusses the benefits that come with being part of the International Generic Pharmaceutical Alliance…

biotech Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow further when they finish development of their second generation botulinum toxin product that will be commercialized globally (outside of Japan and Korea) by Botox manufacturer Allergan. What…